A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

NCT05485753 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Central Nervous System Lymphoma
Secondary Central Nervous System Lymphoma

Interventions

DRUG: GNC-038

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]